HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC.
HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC.
Lohaus, F.; Linge, A.; Baumann, M.
Abstract
There is no abstract
-
Annals of Translational Medicine 3(2015)17, 255
DOI: 10.3978/j.issn.2305-5839.2015.09.35
Cited 8 times in Scopus
Permalink: https://www.hzdr.de/publications/Publ-23169
